Differentiating factors between erythropoiesis-stimulating agents: A guide to selection for anaemia of chronic kidney diseaseDEICHER, Robert; HÖRL, Walter H.Drugs (Basel). 2004, Vol 64, Num 5, pp 499-509, issn 0012-6667, 11 p.Article

Place of Epoetin and Novo7 in Belgian anaesthesia & ICU practice: a clinical perspectiveDE DECKER, K.Acta anaesthesiologica belgica. 2010, Vol 61, Num 3, pp 129-131, issn 0001-5164, 3 p.Conference Paper

Evaluating erythropoietic agents for the treatment of anaemia in the oncology settingGASCON, Pere.European journal of cancer (1990). 2005, Vol 41, Num 17, pp 2601-2612, issn 0959-8049, 12 p.Article

Role of epoetin alfa in maintaining ribavirin doseAFDHAL, Nezam H.Gastroenterology clinics of North America. 2004, Vol 33, Num 1S, pp xviii-xix, issn 0889-8553, 12 p., SUPArticle

The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patientsMOVILLI, Ezio; BRUNORI, Giuliano; CAMERINI, Corrado et al.Blood purification. 2006, Vol 24, Num 4, pp 387-393, issn 0253-5068, 7 p.Article

Is there a place for epoetin alfa in managing anemia during critical illness?GIVENS, Marlea; LAPOINTE, Marc.Clinical therapeutics. 2004, Vol 26, Num 6, pp 819-829, issn 0149-2918, 11 p.Article

A study of the response of elderly patients with end-stage Renal disease to epoetin alfa or betaNICHOLAS, Johann C. B.Drugs & aging. 2004, Vol 21, Num 3, pp 187-201, issn 1170-229X, 15 p.Article

Clinical and economic impact of epoetins in cancer careMARCHETTI, Monia; BAROSI, Giovanni.PharmacoEconomics (Auckland). 2004, Vol 22, Num 16, pp 1029-1045, issn 1170-7690, 17 p.Article

Gentechnische Herstellung von Arzneimitteln und ihre Anwendung am Beispiel des Erythropoetins = Genetically engineered drugs and their application of recombinant erythropoietinDONATZ, V; ZAHNER, J.AINS. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 2001, Vol 36, Num 7, pp 440-444, issn 0939-2661Article

Traitement de l'anémie par injection hebdomadaire chez les patients atteints de cancer : analyse comparative des agents stimulants l'érythropoïèse = Treatment of anaemia in cancer patients by weekly injection : comparison of erythropoiesis stimulating agentsPUJADE-LAURAINE, E; GEAY, J.-F; TOPHAM, C et al.Oncologie (Paris). 2006, Vol 8, Num 5, pp 494-502, issn 1292-3818, 9 p.Article

Evaluation of the Pharmacokinetics of Two Recombinant Human Erythropoietin Preparations: Epoetin Zeta and Epoetin Alfa 2nd Communication: A monocentric, double-blind, randomized, single dose, three-period crossover trial in healthy volunteersKIRKOV, Valentin; DIMITROVA, Velislava; SIEBERT-WEIGEL, Marianne et al.Arzneimittel-Forschung. 2008, Vol 58, Num 5, pp 220-224, issn 0004-4172, 5 p.Article

Is there a possible survival benefit to increasing hemoglobin levels with epoetin alfa during chemotherapy?AAPRO, M; BAJETTA, E; FREUND, M et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 20-28, issn 1359-6349, 9 p.Conference Paper

Epoetin alfa has potential efficacy in central nervous system disordersCERAMI, A; BRINES, M; CERAMI, C et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 29-35, issn 1359-6349, 7 p.Conference Paper

Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patientsCALO, L. A; STANIC, L; DAVIS, P. A et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 5, pp 187-192, issn 0946-1965, 6 p.Article

Recommandations pour la pratique clinique : Standards, Options et Recommandations 2003 pour l'utilisation de l'érythropoïétine recombinante (époetine alfa et bêta, darbepoetine alfa, EPO) dans la prise en charge de l'anémie en cancérologie, mise à jour (rapport abrégé) = Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - update 2003SPAFTH, Dominique; CASAUEVALL, Nicole; DAOUPHARS, Mikaël et al.Bulletin du cancer. 2004, Vol 91, Num 2, pp 179-188, issn 0007-4551, 10 p.Article

Sport et erythropoietine: Rappels, effets et prévention = EPO misuse and sport: Preventive actionDINE, G; VAN LIERDE, F; REHN, Y et al.L' Eurobiologiste (Paris). 2000, Vol 34, Num 245, pp 39-46, issn 0999-5749Article

Epoetin alpha, epoetin beta and darbepoetin alfa: Two-dimensional gel electrophoresis isoforms characterization and mass spectrometry analysisCALDINI, Anna; MONETI, Gloriano; FANELLI, Alessandra et al.Proteomics (Weinheim. Print). 2003, Vol 3, Num 6, pp 937-941, issn 1615-9853, 5 p.Conference Paper

Utilisations thérapeutiques des facteurs de croissance hématopoïétiques. I. Érythropoïétine et thrombopoïétine = Therapeutical uses of haematopoietic growth factorsROYER, B; AROCK, M.Annales de biologie clinique (Paris). 1998, Vol 56, Num 2, pp 143-152, issn 0003-3898Article

Époétine bêta dans le traitement de l'anémie liée à la chimiothérapie dans les tumeurs solides et les hémopathies malignes. Résultats d'un essai clinique, en ouvert, multicentrique = Epoetin beta for the treatment of chemotherapy-induced anaemia in solid and haematological malignancies. Results of an open-label, multicentric clinical trialSPAËTH, D.Bulletin du cancer. 2010, Vol 97, Num 8, pp 969-978, issn 0007-4551, 10 p.Article

Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patientsPUGLISI, Fabio; DEROMA, Laura; BECCAGLIA, Patrizia et al.Critical reviews in oncology/hematology. 2009, Vol 69, Num 2, pp 175-182, issn 1040-8428, 8 p.Article

Utilisation review of epoetin alfa in cancer patients at a cancer centre in SingaporeCHAN, A; LIM, L. L. C; TAO, M et al.Singapore medical journal. 2009, Vol 50, Num 4, pp 365-370, issn 0037-5675, 6 p.Article

Epoetin beta (neorecormon®) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy : a meta-analysisBOOGAERTS, M; OBERHOFF, C; TEN BOKKEL HUININK, W et al.Anticancer research. 2006, Vol 26, Num 1B, pp 479-484, issn 0250-7005, 6 p.Article

PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietinPAPAVASILIOU, Eleni C; GOUVA, Chariklia; SIAMOPOULOS, Kostas C et al.Nephrology, dialysis, transplantation (Print). 2006, Vol 21, Num 5, pp 1270-1277, issn 0931-0509, 8 p.Article

Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer : a meta-analysisAAPRO, M; COIFFIER, B; DUNST, J et al.British journal of cancer. 2006, Vol 95, Num 11, pp 1467-1473, issn 0007-0920, 7 p.Article

Increased injection pain with darbepoetin-a compared to epoetin-β in paediatric dialysis patientsSCHMITT, Claus Peter; NAU, Barbara; BRUMMER, Christiane et al.Nephrology, dialysis, transplantation (Print). 2006, Vol 21, Num 12, pp 3520-3524, issn 0931-0509, 5 p.Article